- Home
- KORE vs ESLA Comparison
KORE vs ESLA Comparison
Compare KORE & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- ESLA
- Stock Information
- Founded
- KORE 2003
- ESLA 2021
- Country
- KORE United States
- ESLA United States
- Employees
- KORE N/A
- ESLA N/A
- Industry
- KORE Telecommunications Equipment
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KORE Consumer Discretionary
- ESLA Health Care
- Exchange
- KORE Nasdaq
- ESLA Nasdaq
- Market Cap
- KORE 39.3M
- ESLA 35.5M
- IPO Year
- KORE N/A
- ESLA N/A
- Fundamental
- Price
- KORE $2.40
- ESLA $0.82
- Analyst Decision
- KORE Hold
- ESLA Strong Buy
- Analyst Count
- KORE 2
- ESLA 1
- Target Price
- KORE $2.75
- ESLA $16.00
- AVG Volume (30 Days)
- KORE 19.9K
- ESLA 18.2K
- Earning Date
- KORE 08-14-2025
- ESLA 08-20-2025
- Dividend Yield
- KORE N/A
- ESLA N/A
- EPS Growth
- KORE N/A
- ESLA N/A
- EPS
- KORE N/A
- ESLA N/A
- Revenue
- KORE $282,254,000.00
- ESLA N/A
- Revenue This Year
- KORE $4.66
- ESLA N/A
- Revenue Next Year
- KORE $6.71
- ESLA N/A
- P/E Ratio
- KORE N/A
- ESLA N/A
- Revenue Growth
- KORE N/A
- ESLA N/A
- 52 Week Low
- KORE $1.10
- ESLA $0.63
- 52 Week High
- KORE $4.88
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- KORE 48.81
- ESLA 42.20
- Support Level
- KORE $2.60
- ESLA $0.82
- Resistance Level
- KORE $2.51
- ESLA $0.95
- Average True Range (ATR)
- KORE 0.16
- ESLA 0.06
- MACD
- KORE -0.02
- ESLA -0.00
- Stochastic Oscillator
- KORE 42.25
- ESLA 23.49
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.